foxo4-dri senolytic or senomorphic Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging Interventions Molecular targets of senolytic drugs.
Pay in 4 interest-free payments of $5.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Live Spec
Molecular targets of senolytic drugs. Download Scientific Diagram The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect
Store: avramcheva.com · Domain: avramcheva.com



























